(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CERVICURA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CERVICURA

ST13

US500000097235343

Class

5

Filing

97235343

Registration

6990283

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

13

Latest update

07/01/2023

Trademark type

Word

Nice classes

5

Filing date

01/24/2022

Registration date

02/28/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/28/2023

Last transaction

07/01/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

Gyeonggi-do, KR

Examiner

VAUSS, JERAMEY

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Genexine, Inc.

Representatives

Patricia A Wilczynski Brozek POKALSKY WILCZYNSKI BROZEK LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

DNA vaccines; preventive vaccines; pharmaceutical preparations for gene therapy; drugs for medical purposespharmaceutical drug preparations for the treatment and prevention of human papilloma virus infectious diseasecancer and cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of head and neck cancer; injectable pharmaceuticals for medical purposesfor the treatment and prevention of human papilloma virus infectious diseasecancer and cervical intraepithelial neoplasia; pharmaceutical preparations for immunomodulatory purposesfor the regulation of immune functions; pharmaceutical preparations for the treatment of cervical cancer; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for the treatment of cervical pre-cancer; vaccines; therapeutic vaccines; pharmaceutical products and preparationsfor the treatment and prevention of human papilloma virus infectious diseasecancer and cervical intraepithelial neoplasia; dermatological pharmaceutical products; antiviral agent against human papilloma virus; preventive vaccines against human papilloma virus infections; pharmaceutical preparations for anticancer immunotherapy; anti-cancer preparations; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia

Publications

History of USPTO decisions and trademark events.

13 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/21/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

06/21/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/21/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/21/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/28/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

02/28/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/13/2022

PUBO

PUBLISHED FOR OPPOSITION

12/13/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/23/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/04/2022

DOCK

ASSIGNED TO EXAMINER

11/02/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/27/2022

NWAP

NEW APPLICATION ENTERED

01/27/2022

Continuous trademark protection

Get notified about every new filing that threatens CERVICURA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.